Simplifying Global Compliance
EUSA Pharma Handed Untitled Letter for Exclusion of Warning
Washington Drug Letter
The FDA has handed an untitled letter to EUSA Pharma for promotional material that omitted contraindications and warnings about its prostate cancer diagnostic imaging agent.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing